These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 18667500)

  • 1. Mutations in human immunodeficiency virus type 1 nucleocapsid protein zinc fingers cause premature reverse transcription.
    Thomas JA; Bosche WJ; Shatzer TL; Johnson DG; Gorelick RJ
    J Virol; 2008 Oct; 82(19):9318-28. PubMed ID: 18667500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human immunodeficiency virus type 1 nucleocapsid zn(2+) fingers are required for efficient reverse transcription, initial integration processes, and protection of newly synthesized viral DNA.
    Buckman JS; Bosche WJ; Gorelick RJ
    J Virol; 2003 Jan; 77(2):1469-80. PubMed ID: 12502862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 nucleocapsid protein and the secondary structure of the binary complex formed between tRNA(Lys.3) and viral RNA template play different roles during initiation of (-) strand DNA reverse transcription.
    Rong L; Liang C; Hsu M; Guo X; Roques BP; Wainberg MA
    J Biol Chem; 2001 Dec; 276(50):47725-32. PubMed ID: 11602578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subtle alterations of the native zinc finger structures have dramatic effects on the nucleic acid chaperone activity of human immunodeficiency virus type 1 nucleocapsid protein.
    Guo J; Wu T; Kane BF; Johnson DG; Henderson LE; Gorelick RJ; Levin JG
    J Virol; 2002 May; 76(9):4370-8. PubMed ID: 11932404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The conserved N-terminal basic residues and zinc-finger motifs of HIV-1 nucleocapsid restrict the viral cDNA synthesis during virus formation and maturation.
    Didierlaurent L; Houzet L; Morichaud Z; Darlix JL; Mougel M
    Nucleic Acids Res; 2008 Aug; 36(14):4745-53. PubMed ID: 18641038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unpaired Guanosines in the 5' Untranslated Region of HIV-1 RNA Act Synergistically To Mediate Genome Packaging.
    Nikolaitchik OA; Somoulay X; Rawson JMO; Yoo JA; Pathak VK; Hu WS
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32796062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleocapsid mutations turn HIV-1 into a DNA-containing virus.
    Houzet L; Morichaud Z; Didierlaurent L; Muriaux D; Darlix JL; Mougel M
    Nucleic Acids Res; 2008 Apr; 36(7):2311-9. PubMed ID: 18296486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blocking premature reverse transcription fails to rescue the HIV-1 nucleocapsid-mutant replication defect.
    Thomas JA; Shatzer TL; Gorelick RJ
    Retrovirology; 2011 Jun; 8():46. PubMed ID: 21682883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human cellular nucleic acid-binding protein Zn2+ fingers support replication of human immunodeficiency virus type 1 when they are substituted in the nucleocapsid protein.
    McGrath CF; Buckman JS; Gagliardi TD; Bosche WJ; Coren LV; Gorelick RJ
    J Virol; 2003 Aug; 77(15):8524-31. PubMed ID: 12857921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human immunodeficiency virus type 1 nucleocapsid zinc-finger mutations cause defects in reverse transcription and integration.
    Thomas JA; Gagliardi TD; Alvord WG; Lubomirski M; Bosche WJ; Gorelick RJ
    Virology; 2006 Sep; 353(1):41-51. PubMed ID: 16784767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleocapsid protein zinc-finger mutants of simian immunodeficiency virus strain mne produce virions that are replication defective in vitro and in vivo.
    Gorelick RJ; Benveniste RE; Gagliardi TD; Wiltrout TA; Busch LK; Bosche WJ; Coren LV; Lifson JD; Bradley PJ; Henderson LE; Arthur LO
    Virology; 1999 Jan; 253(2):259-70. PubMed ID: 9918884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strict conservation of the retroviral nucleocapsid protein zinc finger is strongly influenced by its role in viral infection processes: characterization of HIV-1 particles containing mutant nucleocapsid zinc-coordinating sequences.
    Gorelick RJ; Gagliardi TD; Bosche WJ; Wiltrout TA; Coren LV; Chabot DJ; Lifson JD; Henderson LE; Arthur LO
    Virology; 1999 Mar; 256(1):92-104. PubMed ID: 10087230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cationic Residues of the HIV-1 Nucleocapsid Protein Enable DNA Condensation to Maintain Viral Core Particle Stability during Reverse Transcription.
    Gien H; Morse M; McCauley MJ; Rouzina I; Gorelick RJ; Williams MC
    Viruses; 2024 May; 16(6):. PubMed ID: 38932164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphologic changes in human immunodeficiency virus type 1 virions secondary to intravirion reverse transcription: evidence indicating that reverse transcription may not take place within the intact viral core.
    Zhang H; Dornadula G; Orenstein J; Pomerantz RJ
    J Hum Virol; 2000; 3(3):165-72. PubMed ID: 10881997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular HIV-1 Gag localization is impaired by mutations in the nucleocapsid zinc fingers.
    Grigorov B; Décimo D; Smagulova F; Péchoux C; Mougel M; Muriaux D; Darlix JL
    Retrovirology; 2007 Aug; 4():54. PubMed ID: 17683545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MoMuLV and HIV-1 nucleocapsid proteins have a common role in genomic RNA packaging but different in late reverse transcription.
    Chamontin C; Yu B; Racine PJ; Darlix JL; Mougel M
    PLoS One; 2012; 7(12):e51534. PubMed ID: 23236513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in the Basic Region of the Mason-Pfizer Monkey Virus Nucleocapsid Protein Affect Reverse Transcription, Genomic RNA Packaging, and the Virus Assembly Site.
    Dostálková A; Kaufman F; Křížová I; Kultová A; Strohalmová K; Hadravová R; Ruml T; Rumlová M
    J Virol; 2018 May; 92(10):. PubMed ID: 29491167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rescue of multiple viral functions by a second-site suppressor of a human immunodeficiency virus type 1 nucleocapsid mutation.
    Cimarelli A; Sandin S; Höglund S; Luban J
    J Virol; 2000 May; 74(9):4273-83. PubMed ID: 10756042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. When is it time for reverse transcription to start and go?
    Mougel M; Houzet L; Darlix JL
    Retrovirology; 2009 Mar; 6():24. PubMed ID: 19261185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aromatic residue mutations reveal direct correlation between HIV-1 nucleocapsid protein's nucleic acid chaperone activity and retroviral replication.
    Wu H; Mitra M; McCauley MJ; Thomas JA; Rouzina I; Musier-Forsyth K; Williams MC; Gorelick RJ
    Virus Res; 2013 Feb; 171(2):263-77. PubMed ID: 22814429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.